InflaRx meets primary objective in mid-stage trial for vilobelimab in ANCA vasculitis
May 12 2021 - 6:49AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Apr 2023 to Apr 2024